featured
Atopic March Risk in Pediatric Patients With Atopic Dermatitis Prescribed Dupilumab vs Conventional Immunomodulators
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
J Am Acad Dermatol 2024 Jun 13;[EPub Ahead of Print], TL Lin, YH Fan, KS Fan, CK Juan, YJ Chen, CY WuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.